Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)
China flag China · Delayed Price · Currency is CNY
10.19
-0.41 (-3.87%)
May 21, 2026, 3:04 PM CST

SHE:000590 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
104.24177.71177.29189.77235.42250.68
Trading Asset Securities
43---25.1175.15
Cash & Short-Term Investments
147.24177.71177.29189.77260.53325.83
Cash Growth
1.58%0.24%-6.58%-27.16%-20.04%-4.99%
Accounts Receivable
67.7668.94103.15154.4117.16124.81
Other Receivables
16.2616.1490.2860.5130.116
Receivables
84.0285.08193.43214.91147.27130.82
Inventory
123.64109.57124.78130.09118.2286.59
Prepaid Expenses
-0.522.32-0.030
Other Current Assets
10.625.982.174.793.0610.65
Total Current Assets
365.53378.87499.99539.55529.11553.88
Property, Plant & Equipment
310.12308.31312.66293.81289.75240.89
Long-Term Investments
2.9523.0220.0320.91919
Goodwill
--13.2131.64137.14-
Other Intangible Assets
122.38123.45131.06132.33157.44133.69
Long-Term Accounts Receivable
-2.033.095.057.42-
Long-Term Deferred Tax Assets
15.2214.98.184.095.234.97
Long-Term Deferred Charges
6.437.46.293.322.931.82
Other Long-Term Assets
52.9331.4918.9220.421913.57
Total Assets
875.56889.471,0131,1511,167967.83
Accounts Payable
87.6664.0773.2483.5564.0141.67
Accrued Expenses
23.1938.9743.8846.6250.840.37
Short-Term Debt
--0.75-25.82-
Current Portion of Long-Term Debt
-20.0611.011010.1-
Current Portion of Leases
-1.12.942.362.693
Current Income Taxes Payable
-0.036.82.33.43.85
Current Unearned Revenue
26.0536.1545.3350.1256.1353.42
Other Current Liabilities
58.0340.9552.3153.8258.4544.68
Total Current Liabilities
194.93201.33236.26248.77271.42186.98
Long-Term Debt
505082.228090-
Long-Term Leases
1.160.811.493.075.185.59
Long-Term Unearned Revenue
44.3844.9843.9942.4444.3746.29
Long-Term Deferred Tax Liabilities
5.675.815.155.917.470.02
Other Long-Term Liabilities
37.0237.0543.0742.7246.0946.62
Total Liabilities
333.17339.98412.18422.92464.53285.5
Common Stock
239.47239.47239.47239.47239.47239.47
Additional Paid-In Capital
473.95473.95474.06474.06474.06474.06
Retained Earnings
-172.62-165.81-115.2910.18-15.06-33.21
Total Common Equity
540.8547.61598.25723.72698.47680.32
Minority Interest
1.591.872.994.494.032
Shareholders' Equity
542.38549.49601.23728.2702.5682.32
Total Liabilities & Equity
875.56889.471,0131,1511,167967.83
Total Debt
51.1671.9798.4295.43133.798.58
Net Cash (Debt)
96.08105.7478.8794.34126.74317.24
Net Cash Growth
565.22%34.07%-16.40%-25.56%-60.05%-6.13%
Net Cash Per Share
0.400.440.330.390.531.32
Filing Date Shares Outstanding
239.07239.47239.47239.47239.47239.47
Total Common Shares Outstanding
239.07239.47239.47239.47239.47239.47
Working Capital
170.59177.54263.73290.78257.69366.9
Book Value Per Share
2.262.292.503.022.922.84
Tangible Book Value
418.42424.17453.98459.75403.89546.63
Tangible Book Value Per Share
1.751.771.901.921.692.28
Buildings
-253.52267.95247.28243.93198.81
Machinery
-228.54220.21197.31189.09174.95
Construction In Progress
-23.098.8123.8315.214.18
Source: S&P Global Market Intelligence. Standard template. Financial Sources.